Aberdeen Group plc Lowers Stock Holdings in Corteva, Inc. $CTVA

Aberdeen Group plc lowered its position in shares of Corteva, Inc. (NYSE:CTVA) by 1.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 518,415 shares of the company’s stock after selling 6,629 shares during the period. Aberdeen Group plc owned about 0.08% of Corteva worth $34,749,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CTVA. Chilton Capital Management LLC increased its holdings in shares of Corteva by 18.1% in the third quarter. Chilton Capital Management LLC now owns 445,350 shares of the company’s stock worth $30,119,000 after buying an additional 68,380 shares during the period. TriaGen Wealth Management LLC purchased a new stake in Corteva during the 3rd quarter valued at about $4,284,000. Truist Financial Corp grew its position in Corteva by 4.5% during the 3rd quarter. Truist Financial Corp now owns 321,913 shares of the company’s stock worth $21,771,000 after acquiring an additional 13,910 shares during the last quarter. New York State Teachers Retirement System grew its position in Corteva by 4.5% during the 3rd quarter. New York State Teachers Retirement System now owns 551,389 shares of the company’s stock worth $37,290,000 after acquiring an additional 23,548 shares during the last quarter. Finally, Alberta Investment Management Corp purchased a new position in Corteva in the 3rd quarter worth approximately $5,018,000. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Corteva

In related news, insider Brian Titus sold 8,311 shares of Corteva stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the transaction, the insider directly owned 8,090 shares of the company’s stock, valued at $619,289.50. This trade represents a 50.67% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.14% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

CTVA has been the subject of a number of analyst reports. UBS Group lowered Corteva from a “buy” rating to a “hold” rating in a research note on Monday, February 9th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Corteva from $85.00 to $90.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. Oppenheimer set a $86.00 price target on shares of Corteva in a report on Thursday, February 5th. BNP Paribas Exane increased their price target on shares of Corteva from $72.00 to $74.00 in a research report on Monday, March 9th. Finally, Mizuho raised their price target on shares of Corteva from $80.00 to $82.00 and gave the stock an “outperform” rating in a report on Tuesday, February 17th. Fourteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $83.19.

Corteva Stock Performance

Corteva stock opened at $85.50 on Friday. Corteva, Inc. has a fifty-two week low of $53.40 and a fifty-two week high of $85.56. The stock’s 50 day simple moving average is $77.62 and its two-hundred day simple moving average is $70.10. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43. The stock has a market cap of $57.40 billion, a price-to-earnings ratio of 54.12, a PEG ratio of 2.92 and a beta of 0.68.

Corteva (NYSE:CTVA) last released its earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, meeting analysts’ consensus estimates of $0.22. The company had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The firm’s revenue for the quarter was down 1.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, analysts expect that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, March 16th. Investors of record on Monday, March 2nd were paid a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.8%. The ex-dividend date was Monday, March 2nd. Corteva’s dividend payout ratio (DPR) is presently 45.57%.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.